Bictegravir

Janessa M. Smith, Pharm.D., BCPS

INDICATIONS

FDA

Treatment of ART-naive patients or those that are virologically suppressed on an ART regimen for at least 3 months

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: June 4, 2018